我们通过实时检索，整理了近期围绕 Neuropace, Inc.（NPCE）人工智能布局的公开报道与信息。以下内容均摘自可核实的来源链接，供读者交叉验证。
News Details ### NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting *--Data presentations to feature 18-month NAUTILUS results and new Post Approval Study (PAS) analyses on GTC…
来源：NeuroPace to Highlight Life-Changing Outcomes and
Enhancing iEEG seizure identification and similarity search with Google Cloud ##### Sharanya Desai, Ph.D. Technical Fellow, Director of AI, NeuroPace, Inc. ##### Iris Fang Enterprise Customer Engineer, Google Cloud Globally, epilepsy affects approximately 50 m…
来源：NeuroPace scales ML workloads with Vertex AI | Goo
News Details ### NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care *-- First in a suite of planned NeuroPace AI tools designed to deliver deeper data insights, support clinical outcomes and further enhance efficiency of RNS…
来源：NeuroPace Announces FDA Approval of ECoG Assistant
客观分析
NeuroPace近期动态显示其癫痫诊疗AI布局加速：一是宣布参加2025年美国癫痫学会年会，突出其AI驱动的“Confident Care”临床成果；二是披露与Google Cloud合作，利用Vertex AI扩展iEEG癫痫识别和相似性搜索的机器学习负载；三是其ECoG Assistant™获FDA批准，标志AI辅助癫痫护理从研发走向监管认可。整体数据表明，NeuroPace正将AI嵌入癫痫诊疗全流程，从数据基础设施到临床工具均实现升级。